AbbVie
ABBV
151,24 €
Share price
-2.65%
Change (1 day)
-0.60%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Market capitalization of AbbVie (ABBV)
Market cap: €267.53 Billion
As of April 2025 AbbVie has a market cap of €267.53 Billion. This makes AbbVie the world's 29th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of AbbVie from 2012 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €267.53 B | -11.5% |
| 2024 | €302.29 B | 22.14% |
| 2023 | €247.50 B | -7.11% |
| 2022 | €266.44 B | 26.06% |
| 2021 | €211.36 B | 37.43% |
| 2020 | €153.79 B | 31.58% |
| 2019 | €116.88 B | -1.92% |
| 2018 | €119.17 B | -7.38% |
| 2017 | €128.67 B | 33% |
| 2016 | €96.74 B | 10.92% |
| 2015 | €87.22 B | 1.86% |
| 2014 | €85.62 B | 41.06% |
| 2013 | €60.70 B | 48.77% |
| 2012 | €40.80 B |
End of Day market cap according to different sources
On Apr 15th, 2025 the market cap of AbbVie was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | €111.05 B | -58.49% | 🇺🇸 USA |
 | €88.86 B | -66.79% | 🇺🇸 USA |
 | €584.49 B | 118.47% | 🇺🇸 USA |
 | €135.12 B | -49.49% | 🇺🇸 USA |
 | €115.97 B | -56.65% | 🇺🇸 USA |
 | €15.05 B | -94.37% | 🇺🇸 USA |
 | €63.58 B | -76.23% | 🇬🇧 UK |
 | €184.39 B | -31.08% | 🇬🇧 UK |
 | €8.69 B | -96.75% | 🇺🇸 USA |